Victoria Catalán Selected Research

Aquaglyceroporins

9/2015	Sleeve Gastrectomy Reduces Hepatic Steatosis by Improving the Coordinated Regulation of Aquaglyceroporins in Adipose Tissue and Liver in Obese Rats.
7/2015	Leptin administration restores the altered adipose and hepatic expression of aquaglyceroporins improving the non-alcoholic fatty liver of ob/ob mice.
5/2011	Aquaglyceroporins serve as metabolic gateways in adiposity and insulin resistance control.
4/2011	Insulin- and leptin-mediated control of aquaglyceroporins in human adipocytes and hepatocytes is mediated via the PI3K/Akt/mTOR signaling cascade.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Victoria Catalán Research Topics

Disease

66	Obesity 01/2022 - 01/2004
35	Inflammation (Inflammations) 01/2022 - 03/2006
28	Weight Loss (Weight Reduction) 01/2022 - 03/2006
23	Insulin Resistance 11/2018 - 09/2006
22	Type 2 Diabetes Mellitus (MODY) 01/2022 - 11/2007
13	Morbid Obesity 01/2022 - 03/2006
8	Non-alcoholic Fatty Liver Disease 11/2021 - 07/2012
8	Body Weight (Weight, Body) 09/2019 - 04/2010
6	Hypoxia (Hypoxemia) 08/2021 - 07/2011
5	Fibrosis (Cirrhosis) 01/2022 - 01/2014
5	Neoplasms (Cancer) 01/2018 - 10/2013
4	Metabolic Diseases (Metabolic Disease) 01/2022 - 03/2013
4	Glucose Intolerance 01/2022 - 10/2014
4	Fatty Liver 01/2022 - 01/2017
4	Colonic Neoplasms (Colon Cancer) 08/2021 - 07/2011
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 01/2007
3	Hypertension (High Blood Pressure) 03/2010 - 08/2006
2	Dyslipidemias (Dyslipidemia) 11/2021 - 10/2016
2	Necrosis 10/2018 - 07/2011
2	Abdominal Obesity 01/2017 - 02/2009
2	Hyperglycemia 05/2011 - 04/2011
2	Overweight 01/2010 - 09/2007
1	Weight Gain 01/2022
1	Carcinogenesis 08/2021
1	Hyperinsulinism (Hyperinsulinemia) 06/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019
1	Hyperplasia 09/2018
1	Hypertrophy 09/2018
1	Colorectal Neoplasms (Colorectal Cancer) 01/2018

Drug/Important Bio-Agent (IBA)

17	LeptinIBA 04/2021 - 08/2006
16	Messenger RNA (mRNA)IBA 01/2022 - 03/2006
12	AdipokinesIBA 04/2020 - 01/2007
12	Proteins (Proteins, Gene)FDA Link 01/2020 - 06/2009
9	Glucose (Dextrose)FDA LinkGeneric 06/2021 - 09/2006
9	AdiponectinIBA 09/2019 - 10/2008
8	CytokinesIBA 01/2022 - 11/2007
8	Glycerol (Glycerine)FDA LinkGeneric 01/2020 - 07/2006
8	OsteopontinIBA 01/2017 - 09/2007
7	LipidsIBA 01/2022 - 10/2008
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2014
6	Insulin (Novolin)FDA Link 11/2018 - 10/2008
5	Interleukin-8 (Interleukin 8)IBA 01/2021 - 01/2017
5	Interleukin-6 (Interleukin 6)IBA 01/2021 - 07/2011
5	GhrelinIBA 01/2019 - 03/2010
5	Triglycerides (Triacylglycerol)IBA 01/2018 - 07/2006
4	Protein Isoforms (Isoforms)IBA 01/2022 - 03/2010
4	Angiopoietin-Like Protein 8IBA 11/2021 - 10/2014
4	HDL CholesterolIBA 01/2018 - 01/2010
4	AquaglyceroporinsIBA 09/2015 - 04/2011
3	Biological ProductsIBA 01/2022 - 01/2004
3	Chemotactic FactorsIBA 01/2022 - 01/2011
3	Conditioned Culture MediaIBA 01/2022 - 01/2021
3	salicylhydroxamic acid (SHAM)IBA 11/2021 - 02/2012
3	LipopolysaccharidesIBA 08/2021 - 10/2018
3	InterleukinsIBA 08/2021 - 12/2016
3	InflammasomesIBA 01/2021 - 01/2018
3	Interleukin-18 (Interleukin 18)IBA 01/2021 - 01/2018
3	fibroblast growth factor 21IBA 01/2021 - 01/2017
3	des-n-octanoyl ghrelinIBA 01/2019 - 03/2010
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2018 - 06/2009
3	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2017 - 03/2006
3	Lipocalin-2IBA 05/2015 - 07/2011
2	Dietary Fats (Dietary Fat)IBA 01/2022 - 06/2021
2	Hormones (Hormone)IBA 06/2021 - 03/2010
2	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 10/2017 - 01/2017
2	TenascinIBA 01/2016 - 10/2012
2	IronIBA 04/2014 - 09/2013
2	MicroRNAs (MicroRNA)IBA 05/2013 - 09/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2013 - 11/2007
2	Complement System Proteins (Complement)IBA 09/2012 - 01/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2011 - 08/2010
1	prouroguanylinIBA 01/2022
1	Cathepsin GIBA 01/2022
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2022
1	Interleukin-1 (Interleukin 1)IBA 01/2022
1	guanylinIBA 01/2022
1	preproguanylinIBA 01/2022
1	microfibrillar proteinIBA 08/2021
1	NeuropeptidesIBA 06/2021
1	Interleukin-33IBA 01/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2020
1	Exenatide (Byetta)FDA Link 04/2019
1	Glucagon-Like Peptide 1 (GLP 1)IBA 04/2019
1	Indicators and Reagents (Reagents)IBA 02/2019
1	AlarminsIBA 01/2019
1	AcyltransferasesIBA 01/2019
1	kallistatinIBA 10/2018
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 10/2017
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2017
1	C-Reactive ProteinIBA 01/2017
1	MineralsIBA 01/2017
1	Thiobarbituric Acid Reactive SubstancesIBA 01/2017

Therapy/Procedure

14	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2022 - 03/2006
13	Bariatric Surgery 01/2022 - 04/2014
11	Gastrectomy 01/2022 - 09/2011
5	Caloric Restriction 01/2022 - 09/2012
4	Therapeutics 06/2021 - 01/2016
2	Operative Surgical Procedures 09/2012 - 02/2012
1	Precision Medicine 01/2018